Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-11

Clinical Trial Update: Clinical Evaluation of the AccuCinch® Ventricular Restoration System in Patients Who Present With Symptomatic Heart Failure With Reduced Ejection Fraction (HFrEF): The CORCINCH-HF Study [NA]

View source ↗

Summary

The CORCINCH-HF trial evaluating the AccuCinch Ventricular Restoration System for symptomatic heart failure with reduced ejection fraction is currently recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AccuCinch Ventricular Restoration System

Snippet

Sponsor: Ancora Heart, Inc. | Conditions: Heart Failure With Reduced Ejection Fraction (HFrEF), Dilated Cardiomyopathy | NA | Status: RECRUITING